Deltamethrin dosea | Study roundb | Oocyst prevalence (%) (95% CI) | Comparison of prevalence between rounds | Mean number of oocysts/midgut (95% CI) | Analysis of variance |
---|---|---|---|---|---|
Control | 1 | 92.7 (84.2–96.8) | χ2 = 94.14; P < 0.0001 | 12.45 (10.00–14.89) | F(2, 252) = 12.32; P < 0.0001 |
2 | 41.2 (23.3–61.8) | 2.96 (2.33–3.59) | |||
3 | 82.7 (67.3–91.8) | 8.78 (6.75–10.80) | |||
Low dose | 1 | 79.5 (44.8–94.9) | χ2 = 29.05 P = 0.0020 | 8.48 (5.95–11.01) | F(2, 67) = 6.42; P = 0.0028 |
2 | 25.8 (18.2–35.2) | 1.00 (1.00–1.00) | |||
3 | 81.6 (72.8–87.9) | 5.03 (3.18–6.88) | |||
High dose | 1 | 71.4 (52.9–84.7) | χ2 = 43.23 P = 0.0069 | 8.55 (6.58–10.51) | F(2, 111) = 11.93; P < 0.0001 |
2 | 23.7 (7.0–56.1) | 2.17 (1.37–2.97) | |||
3 | 60.0 (64.5–82.9) | 4.86 (3.55–6.17) |